ChatGPT 1984 style………
Cleaning Man at Flophouse: Hey, buddy. You got a dead cat in there, or what?
[the Terminator visualizes: 'POSSIBLE RESPONSE: YES/NO; OR WHAT?; GO AWAY; PLEASE COME BACK LATER; FCUK YOU, A55hole; FCUK YOU']
The Terminator: FCUK you, a55hole
Based on 2022 timings, we should also see Notice Of Results soon, for the 6 months ended 31st Oct and the results themselves, in the first half of December. That will hopefully underpin the “in-line” statement from the Company and as a consequence, fuel more upwards momentum into 2024.
Thanks for response but I don’t interpret reference to the last 6 months in the way you do.
“ Attractive financial profile: The business has a profitable track record over the past five years, driven by an average annual growth rate in revenues of 6%. In the year ended 28th February 2023 the business reported unaudited revenues of £3.4m and an EBIT of £0.8m. Trading over the past six months is consistent with delivering a further improvement in performance. The acquisition is expected to be immediately EPS enhancing.”
I read that as just saying in the last 6 months, they have continued to increase revenue & profitability, as they have proven to do in the past.
Could also be that there is one or more other acquisitions in the pipeline that tie-in. We know they have plenty of financial firepower still in the bank.
I wasn’t expecting the SP to explode North today (and am sure you weren’t either) but I do think this acquisition will in reasonable time, prove both complimentary and add value. One thing I particularly like about IVS, is the business they have carved out with household name / blue chip companies. That business wouldn’t come through the door continuously, if the products, support and management (being kept on) were not high standard. More doors will open I believe, leading to that value-add.
But as you say Trotsky, we will see.
It’s always good to hear different angles. However, I’ll go with what the Company is saying re strategic synergies.
“ Expanding market opportunities in smart sensing: by leveraging the Group's platform, IVS will have the access, expertise and resources to scale. There are clear opportunities to expand its geographic footprint and grow its IP-rich static technology offering with prospects to benefit from Vicon's dynamic sensing.”
Https://businesscloud.co.uk/news/oxford-metrics-plc-senses-value-in-8-1m-swoop/
What makes you think they overpaid?
It’s been a very long wait since the sale of Yotta back in May 2022. Months of due diligence no doubt and the strategic synergies seem very transparent. An exciting acquisition imo.
Great news and thanks Berm.
Could it be then, that Guys & St Thomas’, Southampton and Royal Free, were waiting for data readouts at a level that gave them the confidence needed, to commit everything that will be needed to begin recruitment?
Something appears to be building up nicely and a catalyst for volume of data in 2024 - aligning to statements made in todays Results RNS.
Well, I am more than happy to hold my hands up and openly admit I got it wrong about the Results publication date. I expected a suspension, so great news for the wider profile of the Company in the marketplace. Tar can stick, even when not at fault.
Now I’m thinking about whether the next big inflection point could perhaps be after early April 24, to provide an opportunity to whack a further £20k in my ISA!
Lots to look forward to but as always here, patience and belief will be required.
Dragon - don't get your point.
If you're referring to the performance of the ALTYN SP after the suspension was lifted, that could be for a myriad of reasons and given that they are unrelated to Scancell, what would be the relevance here??
Suggest look back at 2022 Results RNS to see possible content / format of this years, rather than relying on the experts here. Whenever it finally arrives of course.
https://www.lse.co.uk/rns/SCLP/results-for-the-year-ended-30-april-2022-yetdif6auz7s3iq.html